Many efforts were done in the last decades to selectively transport antitumor agents to their potential target sites with the aim to improve efficacy and selectivity. Indeed, this aspect could greatly improve the beneficial effects of a specific anticancer agent especially in the case of orphan tumors like the triple negative breast cancer. A possible strategy relies on utilizing a protective leaving group like alizarin as Pt(II) ligand, to reduce the deactivation processes of the pharmacophore enacted by Pt resistant cancer cells. In this study a new series of neutral mixed-ligand Pt(II) complexes bearing alizarin and a variety of diamine ligands were synthetized and spectroscopically characterized by FT-IR, NMR and UV-Vis analyses. Three Pt(II) compounds, i.e., 2b, 6b and 7b, emerging as different both in terms of structural properties and cytotoxic effects (not effective, 10.49 ± 1.21 µM and 24.5±1.5 µM, respectively), were chosen for a deeper investigation of the ability of alizarin to work as a selective carrier. The study comprises the in vitro cytotoxicity evaluation against triple negative breast cancer cell lines and ESI-MS interaction studies relative to the reaction of the selected Pt(II) complexes with model proteins and DNA fragments, mimicking potential biological targets. Results allow us to suggest the use of complex 6b as a prospective anticancer agent worthy of further investigations.

Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation / R. Caligiuri, L. Massai, A. Geri, L. Ricciardi, N. Godbert, G. Facchetti, M.G. Lupo, I. Rossi, G. Coffetti, M. Moraschi, E. Sicilia, V. Vigna, L. Messori, N. Ferri, G. Mazzone, I. Aiello, I. Rimoldi. - In: DALTON TRANSACTIONS. - ISSN 1477-9226. - (2024), pp. 1-17. [Epub ahead of print] [10.1039/d3dt03889k]

Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation

G. Facchetti
;
G. Coffetti;M. Moraschi;I. Rimoldi
Ultimo
2024

Abstract

Many efforts were done in the last decades to selectively transport antitumor agents to their potential target sites with the aim to improve efficacy and selectivity. Indeed, this aspect could greatly improve the beneficial effects of a specific anticancer agent especially in the case of orphan tumors like the triple negative breast cancer. A possible strategy relies on utilizing a protective leaving group like alizarin as Pt(II) ligand, to reduce the deactivation processes of the pharmacophore enacted by Pt resistant cancer cells. In this study a new series of neutral mixed-ligand Pt(II) complexes bearing alizarin and a variety of diamine ligands were synthetized and spectroscopically characterized by FT-IR, NMR and UV-Vis analyses. Three Pt(II) compounds, i.e., 2b, 6b and 7b, emerging as different both in terms of structural properties and cytotoxic effects (not effective, 10.49 ± 1.21 µM and 24.5±1.5 µM, respectively), were chosen for a deeper investigation of the ability of alizarin to work as a selective carrier. The study comprises the in vitro cytotoxicity evaluation against triple negative breast cancer cell lines and ESI-MS interaction studies relative to the reaction of the selected Pt(II) complexes with model proteins and DNA fragments, mimicking potential biological targets. Results allow us to suggest the use of complex 6b as a prospective anticancer agent worthy of further investigations.
Settore CHIM/03 - Chimica Generale e Inorganica
2024
3-gen-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
Cytotoxic-Ptii-complexes-containing-alizarin-a-selective-carrier-for-DNA-metalationDalton-Transactions.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.76 MB
Formato Adobe PDF
1.76 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1027429
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact